Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer [Phase 3]
A Phase 3 study comparing nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment [Phase 2]
Phase 2 trial evaluating paclitaxel, bevacizumab and pemetrexed in untreated advanced non-small cell lung cancer using web-based data collec…
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy
This clinical trial update describes an observational study of erlotinib as second-line therapy in locally advanced or metastatic non-small …
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating cediranib with paclitaxel and carboplatin in stage IIIB/IV non-small cell lung cancer has completed; results posted…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Ombrabulin (AVE8062) in combination with taxane- and platinum-based chemotherapy for non-small cell lung cancer h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea
Completed clinical trial evaluating a powered surgical stapler during video-assisted thoracoscopic lung resections for non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC [Phase 2]
Phase 2 clinical trial update describing a study comparing S1 versus pemetrexed plus carboplatin in patients with EGFR wild-type, nonsquamou…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating Tarceva (erlotinib) in combination with platinum-based therapy versus placebo with platinum in first-line advance…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L) [Phase 2]
GRN1005 was studied in a Phase 2 trial (GRABM-L) for non-small cell lung cancer with brain metastases. The study is terminated and results h…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Afatinib vs Erlotinib as 2nd TKI After Failure to 1st TKI and Chemotherapy for Metastatic NSCLC [Phase 2]
A Phase 2 trial compares afatinib versus erlotinib as second TKI therapy after failure of a first TKI and chemotherapy in metastatic non-sma…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1, Phase 2]
ClinicalTrials.gov reports a Phase 1b/2 study of carfilzomib in relapsed solid tumors, multiple myeloma, or lymphoma. The study is completed…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of AVAX's DNP-modified autologous tumor cell vaccine for completely resectable non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation [Phase 2]
Phase 2 study evaluating REOLYSIN in combination with paclitaxel and carboplatin for non-small cell lung cancer with KRAS or EGFR activation…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer [Phase 3]
This clinical trial update reports the results of a Phase 3 study evaluating chemotherapy and radiation in participants with stage 3 non-sma…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) [Phase 3]
A Phase 3 trial (START) evaluating the belagenpumatucel-L cancer vaccine in unresectable stage III non-small cell lung cancer has completed.…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer [NA]
This clinical trial update reports results for an adjuvant triple-drug regimen (docetaxel, vinorelbine, and bevacizumab) in patients with re…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations [Phase 2]
A phase 2 trial evaluating the combination of erlotinib and AT-101 in advanced non-small cell lung cancer with EGFR activating mutations was…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON) [Phase 2]
Phase 2 trial evaluating erlotinib in combination with chemotherapy for stage IB-IIIA non-small cell lung cancer with EGFR mutations has com…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy
A completed clinical trial evaluating imaging biomarkers (FDG PET/CT, diffusion-weighted MRI, and dynamic contrast-enhanced MRI) as predicto…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer) [Phase 2]
Phase 2b randomized trial of Tecemotide (L-BLP25) for non-small cell lung cancer completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy [Phase 2]
Phase 2 trial of RO4929097 in advanced non-small cell lung cancer patients recently treated with front-line chemotherapy; the study was term…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer [Phase 2]
A completed Phase 2 trial evaluating a combination of cetuximab, paclitaxel, carboplatin, and radiation therapy in patients with unresectabl…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating chemotherapy plus radiation therapy with or without surgery for Stage IIIA non-small cell lung cancer. The study st…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer [Phase 1]
This completed Phase 1 clinical trial evaluated adding gemcitabine with either carboplatin or paclitaxel plus radiation therapy in patients …
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN) [Phase 2]
Phase 2 trial evaluating erlotinib as monotherapy or intermittent dosing with docetaxel in advanced or metastatic non-small cell lung cancer…